Special Report: Preparing for Stage 1 of the FDA’s LDTs Final Rule
Considerations for addressing compliance with Stage 1 of the FDA’s lab-developed tests final rule
Lab Compliance Advisor
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
Subscribe today for access to
Articles and Reports
How the LDT Final Rule’s Exemptions Apply to Oncology Labs
Regulatory expert explores whether any exclusions might benefit cancer laboratories trying to navigate upcoming compliance deadlines
FDA Watch: FDA Approves Enhanced Cologuard Cancer Test
Test maker Exact Sciences says it expects Cologuard Plus to cut false positives by more than 30 percent
HHS Releases OIG Seminannual Report to Congress
From - G2 Compliance Advisor
The U.S. Department of Health and Human Services' Office of Inspector General (OIG) touted its efforts and achievements for the six-month period ending…
CMS Releases Data on Medicare Payments to Providers, Including Clinical Labs
From - G2 Compliance Advisor
For a third year in a row, the Centers for Medicare & Medicaid Services (CMS) has released updated data regarding Medicare payments with its Physician and…
OIG Video Spotlights Physician Kickbacks
From - G2 Compliance Advisor
The U.S. Health and Human Services Office of Inspector General's (OIG's) concern about kickbacks to referral sources is…
Tread Carefully When Disciplining Employees Who Have Blown the Whistle
From - G2 Compliance Advisor
The False Claims Act (FCA) has become the federal government's primary weapon in combating fraud and abuse. However, most FCA cases are initiated not by the government but…
Drug Testing Enforcement Cases Lead to Costly Settlements and Convictions
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Labs with International Aspirations Need to Focus on FCPA Compliance Challenges
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Nearly Half of Top 10 Patient Safety Concerns Relevant to Labs
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
After the Whistle Blows: Disciplining Whistleblowers without Committing Retaliation
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Theranos Faces New Challenges and Increasing Federal Scrutiny
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Take Steps Now to Establish Quality Systems for LDTs
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here